TRABOULSEE STUDY & the Conflict of Interest @TheLancet (http://www.ncbi.nlm.nih.gov/pubmed/24119384) https://www.facebook.com/photo.php?fbid=775895155812553&set=a.116899871712088.18007.100001762281491&type=1&theater


Tijdlijnfoto's
TRABOULSEE STUDY (http://www.ncbi.nlm.nih.gov/pubmed/24119384)
Conflicts of interest
ALT has received grant funding from the MS Society of Canada, the Canadian Institute for Health Research, the Lotte and John Hecht Foundation, the Vancouver Hospital Foundation, Bayer, Roche, and Biogen. He has served on the data safety monitoring board for Merck Serono and the clinical trial steering committee for Roche. He has received honoraria or travel grants from Biogen, Teva Canada Innovation, Roche, Merck/EMD Serono, and Chugai Pharmaceuticals. He was a member of the Canadian Institute for Health Research and the Multiple Sclerosis Society of Canada Scientific Expert Working Group on Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis. KBK has received grant funding from Saskatoon City Hospital Foundation and the Multiple Sclerosis Society of Canada, educational Continuing Medical Education event grant funding from Bayer HealthCare Pharmaceuticals, and honoraria or travel grants from Biogen and Teva. She was a member of the Canadian Institute for Health Research and the Multiple Sclerosis Society of Canada Scientific Expert Working Group on Chronic Cerebrospinal Venous Insufficiency and Multiple Sclerosis. DKL has received research funding from the Canadian Institute of Health Research and the Multiple Sclerosis Society of Canada. He is the director of the University of British Columbia Multiple Sclerosis/MRI Research Group, which has been contracted to perform central analysis of MRI scans for clinical trials with Angiotech, Bayer, Berlex-Schering, Bio-MS, Boehringer-Ingelheim, Centocor, Daiichi Sankyo, Genentech, Genzyme, F Hoffmann-La Roche, Merck Serono, Nuron, Perceptives, Schering-Plough, Teva Neurosciences, Sanofi -Aventis, and Transition Therapeutics. He has acted as consultant to Genzyme and has served on the scientific advisory boards for Novartis, Nuron, and Roche, and the data safety monitoring board for Opexa. DS has received grant support from the Multiple Sclerosis Society of Canada Scientific Research Foundation, the Canadian Institute for Health Research, and the Alzheimer Society of Canada. She has received travel support and honoraria from Biogen Idec, Teva Neuroscience, and Merck Serono. She is a paid consultant on a Novartis multiple sclerosis study. AR has received grant support from the Canadian Institute of Health Research and the Natural Sciences and Engineering Research Council of Canada. LM is a member of the Research Steering Committee for Cook and Medical Advisory Board for Boston Scientific Corporation. YZ, IY, DKl, DKo, SL, RO, and PS declare that they have no conflicts of interest. — met Franz Schelling en 20 anderen.